Fundraising FoxAtypical Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Robert DiFazio(Founder)inJuliana Hilliard(Founder)injennifer lee(Vice President of Finance \u0026 Operations)Christopher Riling(Vice President of Science)
Co-investorsAIX VenturesBreakout VenturesGaingelsHumba VenturesImmeasurableJulian Capital+19 more
__Twitter.png)
.jpeg){kind=logo}
Portal Space Systems develops advanced spacecraft, including its flagship Supernova vehicle, designed for high delta-v maneuverability and multi-orbit operations in cislunar space.
Deep TechHardwareSpace TechWashington, US
Jeffery Thornburg(Executive Officer, Director, Promoter)Ian Vorbach(Founder)inPrashaanth Ravindran(Founder)inJeff Thornburg(Founder)
BoardRayfe Gaspar-Asaoka(Director)in
Co-investorsAlleyCorpBooz Allen VenturesFUSEGeodesic CapitalIceNineTFX Capital+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.